Delivery Order SPE2DB22D3401-SPE2DB24FT4EB

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The order has a ceiling value of $8,109.36 and an ultimate completion date of July 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $2,827.52 and an ultimate completion date of June 18, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with a ceiling value of $23,604.03 and a final completion date of June 25, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp., for the procurement of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $12,388.11 and a completion date of January 8, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565455816 - CONTRAVE ER 8-90 MG TABLET 120S. The firm-fixed-price contract has a ceiling value of $7,785.50 and an ultimate completion date of August 15, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a ceiling value of $29,803.99 and a completion date of September 3, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen, through its Corporate Office Division, will be providing these prescription medications to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.76, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 120 tablets of the medication CONTRAVE ER 8-90 MG and has a ceiling value of $1,008.21. The contract has an ultimate completion date of October 23, 2023 and was awarded on October 20, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a ceiling value of $9,947.76 and a performance period through September 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these tablets to support military treatment facilities and other federal healthcare...
This is a delivery order awarded to Amerisourcebergen Drug Corporation by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $1,439.80. The order is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4EB
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for CONTRAVE ER 8-90 MG TABLET 120S, a prescription pharmaceutical product. The contract has a ceiling value of $8,712.24 and a delivery completion date of August 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military healthcare programs. The contract does not have a set-aside designation.

Generated 11/11/24, 9:31 AM